UPDATE 1-AbbVie to buy cancer drug maker Pharmacyclics in $21 bln deal
March 04, 2015 at 23:28 PM EST
March 4 (Reuters) - Drugmaker AbbVie Inc said it will buy Pharmacyclics Inc, the maker of blockbuster cancer drug Imbruvica, for about $21 billion to boost its oncology drugs pipeline.
